ACE2 and COVID-19: VLP-mediated delivery to ACE2-expressing permissive cells could generate a robust antiviral response that could mitigate SARS-CoV-2 infection while avoiding an exacerbated inflammatory reaction or cytokine storm leading the development of severe COVID-19 (Hsu et al., 2022).